Citigroup analyst Steven Zaccone maintains Best Buy Co (NYSE:BBY) with a Sell and raises the price target from $61 to $72.
Amneal Receives U.S. FDA Approval For Calcium Gluconate Injection; Key Injectable Currently On The U.S. FDA Shortage List; Received Competitive Generic Therapy Approval Designation
- Key injectable currently on the U.S. FDA shortage list
- Received Competitive Generic Therapy approval designation
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) ("Amneal" or the
